Simultaneous in vivo detection of spectrally resolved glutamate, glutamine, and glutathione at 3 T with NAA ‐aspartyl editing and echo‐time optimization
Magnetic Resonance in Medicine · 2026
DOI: 10.1002/mrm.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2026. Verfasst von Li An und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Glutamine, Glutathione, Glutamic Acid, Aspartic Acid. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Purpose
To achieve spectrally resolved in vivo detection of glutamate, glutamine, and glutathione at 3 T.
Methods
Difference editing of N‐acetylaspartate CH 2 protons (NAA‐CH 2 ) combined with a new echo‐time (TE) optimization approach is introduced. Difference editing was used to detect NAA‐CH 2 independently of NAA‐CH 3 , thereby eliminating systematic errors arising from constrained fitting of the entire NAA molecule. Numerical optimization of TE and TE 1 minimized interference from highly dominant glutamate in glutamine detection in the ON/OFF sum spectrum. In vivo data were acquired from 6 healthy participants, including 2 who underwent oral administration of [U‐ 13 C]glucose.
Results
The NAA‐aspartyl‐edited, cleaned‐up in vivo spectrum showed distinct separation of glutamate, glutamine, and glutathione peaks at 3 T, facilitating spectral quantification and clinical applications. The post‐ 13 C proton MR‐spectroscopy spectra clearly demonstrated the dynamic 13 C‐labeling of glutamate C4 following oral [U‐ 13 C]glucose intake.
Conclusion
This technique enables simultaneous spectral resolution of glutamate, glutamine, and glutathione peaks at 3 T using difference editing of NAA‐CH 2 and an optimized TE of 85 ms. Additionally, it demonstrates, for the first time, the feasibility of measuring 13 C turnovers of spectrally resolved glutamate at 3 T with the high sensitivity and spatial resolution of proton MR spectroscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Li An, Sungtak Hong
Förderung
- Intramural NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
An, L., Hong, S., Turon, T., Pavletic, A. J., Johnson, C. S., & Shen, J. (2026). Simultaneous in vivo detection of spectrally resolved glutamate, glutamine, and glutathione at 3 T with NAA ‐aspartyl editing and echo‐time optimization. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.70076
Vancouver
An L, Hong S, Turon T, Pavletic AJ, Johnson CS, Shen J. Simultaneous in vivo detection of spectrally resolved glutamate, glutamine, and glutathione at 3 T with NAA ‐aspartyl editing and echo‐time optimization. Magnetic Resonance in Medicine. 2026. doi:10.1002/mrm.70076
BibTeX
@article{An2026,
author = {An, Li and Hong, Sungtak and Turon, Tara and Pavletic, Adriana J and Johnson, Christopher S and Shen, Jun},
title = {Simultaneous in vivo detection of spectrally resolved glutamate, glutamine, and glutathione at 3 T with NAA ‐aspartyl editing and echo‐time optimization},
journal = {Magnetic Resonance in Medicine},
year = {2026},
doi = {10.1002/mrm.70076}
}
EUVIMED